adamantane has been researched along with scopolamine hydrobromide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gmiro, VE; Lukomskaia, NIa; Zhabko, EP | 1 |
| Asin, KE; Wirtshafter, D | 1 |
| Brown, CM; Lu, D; Makriyannis, A; McLaughlin, PJ; Salamone, JD; Thakur, G; Winston, KM | 1 |
| Azmi, N; Bennett, GW; Norman, C; Spicer, CH | 1 |
| Berke, JD; Fensterheim, BA; Gittis, AH; Kreitzer, AC; Leventhal, DK; Pettibone, JR | 1 |
| Alexandrova, A; Bibi, A; Dragomanova, S; Georgieva, A; Kalfin, R; Lazarova, M; Munkuev, A; Reynisson, J; Salakhutdinov, N; Stefanova, M; Suslov, E; Tancheva, L; Tzvetanova, E; Uzunova, D; Volcho, K | 1 |
6 other study(ies) available for adamantane and scopolamine hydrobromide
| Article | Year |
|---|---|
[The participation of glutaminergic transmission in the mechanism of movement disorders induced by reverse rotation in white mice].
Topics: Adamantane; Animals; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred Strains; Movement Disorders; Muscarinic Antagonists; Receptors, Glutamate; Rotation; Scopolamine; Time Factors | 1999 |
Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat.
Topics: Adamantane; Animals; Benzopyrans; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Immunohistochemistry; Male; Muscarinic Antagonists; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Scopolamine | 2001 |
The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats.
Topics: Adamantane; Animals; Dose-Response Relationship, Drug; Dronabinol; Mice; Muscarinic Antagonists; Pattern Recognition, Visual; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Scopolamine; Task Performance and Analysis | 2005 |
Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.
Topics: Adamantane; Animals; Brain; Depression, Chemical; Discrimination, Psychological; Dose-Response Relationship, Drug; Form Perception; Imidazoles; Injections, Intraventricular; Male; Memory, Short-Term; Muscarinic Antagonists; Neurotensin; Rats; Receptors, Neurotensin; Scopolamine; Space Perception | 2006 |
Selective inhibition of striatal fast-spiking interneurons causes dyskinesias.
Topics: Action Potentials; Adamantane; Analysis of Variance; Animals; Area Under Curve; Cholinergic Antagonists; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Functional Laterality; Green Fluorescent Proteins; Interneurons; LIM-Homeodomain Proteins; Male; Mecamylamine; Mice; Mice, Transgenic; N-Methylaspartate; Nerve Tissue Proteins; Scopolamine; Transcription Factors | 2011 |
New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.
Topics: Acetylcholinesterase; Adamantane; Alzheimer Disease; Animals; Antioxidants; Bicyclic Monoterpenes; Maze Learning; Neurodegenerative Diseases; Neuroprotective Agents; Norepinephrine; Oxidative Stress; Rats; Rats, Wistar; Scopolamine; Serotonin | 2022 |